 Suzanne Lareau
Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 30 | 2022 | 1137 | 4.170 |
Why?
| | Dyspnea | 14 | 2021 | 201 | 1.650 |
Why?
| | Fatigue | 4 | 2023 | 297 | 1.100 |
Why?
| | Medication Adherence | 4 | 2020 | 556 | 1.080 |
Why?
| | Patient Education as Topic | 7 | 2018 | 699 | 1.010 |
Why?
| | Lung Diseases | 6 | 2021 | 718 | 0.980 |
Why?
| | Exercise Therapy | 6 | 2016 | 355 | 0.960 |
Why?
| | Small Cell Lung Carcinoma | 1 | 2021 | 83 | 0.760 |
Why?
| | Activities of Daily Living | 8 | 2019 | 354 | 0.750 |
Why?
| | Cardiac Rehabilitation | 1 | 2020 | 33 | 0.700 |
Why?
| | Lung Diseases, Obstructive | 6 | 1999 | 44 | 0.700 |
Why?
| | Motor Activity | 3 | 2020 | 660 | 0.620 |
Why?
| | Disability Evaluation | 1 | 2019 | 280 | 0.590 |
Why?
| | Smoking Cessation | 2 | 2021 | 360 | 0.580 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 2 | 2022 | 968 | 0.580 |
Why?
| | Patient Reported Outcome Measures | 1 | 2018 | 252 | 0.570 |
Why?
| | Oxygen Inhalation Therapy | 3 | 2016 | 124 | 0.560 |
Why?
| | Respiration | 1 | 2017 | 183 | 0.560 |
Why?
| | Patient Compliance | 2 | 2020 | 537 | 0.560 |
Why?
| | Self Care | 3 | 2016 | 357 | 0.550 |
Why?
| | Health Education | 1 | 2018 | 318 | 0.540 |
Why?
| | Bronchodilator Agents | 4 | 2019 | 253 | 0.540 |
Why?
| | Goals | 1 | 2017 | 167 | 0.530 |
Why?
| | Respiration, Artificial | 3 | 2017 | 545 | 0.520 |
Why?
| | Respiration Disorders | 3 | 2023 | 66 | 0.500 |
Why?
| | Quality of Life | 9 | 2021 | 2366 | 0.500 |
Why?
| | Nebulizers and Vaporizers | 2 | 2011 | 82 | 0.500 |
Why?
| | Telemedicine | 2 | 2020 | 664 | 0.490 |
Why?
| | Health Status | 3 | 2018 | 726 | 0.480 |
Why?
| | Disease Progression | 4 | 2018 | 2490 | 0.430 |
Why?
| | Lung Neoplasms | 2 | 2022 | 2220 | 0.420 |
Why?
| | Heart Failure | 3 | 2020 | 1969 | 0.420 |
Why?
| | Humans | 54 | 2023 | 118974 | 0.400 |
Why?
| | Frailty | 2 | 2023 | 116 | 0.380 |
Why?
| | Surveys and Questionnaires | 11 | 2019 | 4708 | 0.350 |
Why?
| | Pamphlets | 2 | 2018 | 25 | 0.330 |
Why?
| | Delivery of Health Care, Integrated | 3 | 2018 | 233 | 0.320 |
Why?
| | Critical Care | 1 | 2012 | 492 | 0.320 |
Why?
| | Glucocorticoids | 1 | 2011 | 545 | 0.300 |
Why?
| | Critical Illness | 3 | 2018 | 662 | 0.280 |
Why?
| | Health Status Indicators | 3 | 2008 | 154 | 0.260 |
Why?
| | Self-Assessment | 1 | 2004 | 63 | 0.240 |
Why?
| | Metered Dose Inhalers | 2 | 2014 | 18 | 0.230 |
Why?
| | Pneumonectomy | 2 | 2021 | 115 | 0.230 |
Why?
| | Telerehabilitation | 1 | 2023 | 26 | 0.230 |
Why?
| | Respiratory Tract Diseases | 2 | 2023 | 143 | 0.220 |
Why?
| | Terminology as Topic | 1 | 2004 | 211 | 0.220 |
Why?
| | Exercise Tolerance | 4 | 2014 | 233 | 0.220 |
Why?
| | Chemoradiotherapy, Adjuvant | 1 | 2021 | 42 | 0.210 |
Why?
| | Walking | 1 | 2006 | 415 | 0.210 |
Why?
| | Reproducibility of Results | 6 | 2019 | 2874 | 0.200 |
Why?
| | Societies, Medical | 4 | 2018 | 703 | 0.200 |
Why?
| | Karnofsky Performance Status | 1 | 2019 | 36 | 0.170 |
Why?
| | Respiratory Therapy | 1 | 2018 | 19 | 0.160 |
Why?
| | Interdisciplinary Studies | 1 | 2018 | 26 | 0.160 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1440 | 0.160 |
Why?
| | Neoplasm Staging | 1 | 2021 | 1223 | 0.160 |
Why?
| | Education | 1 | 2018 | 105 | 0.160 |
Why?
| | Psychometrics | 2 | 2019 | 631 | 0.160 |
Why?
| | Medical History Taking | 1 | 1998 | 120 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 360 | 0.150 |
Why?
| | Adrenal Cortex Hormones | 2 | 2019 | 521 | 0.150 |
Why?
| | Spirometry | 1 | 1998 | 263 | 0.150 |
Why?
| | Equipment and Supplies | 1 | 2017 | 39 | 0.150 |
Why?
| | Muscarinic Antagonists | 1 | 2017 | 25 | 0.150 |
Why?
| | Smoking | 2 | 2021 | 1487 | 0.150 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2017 | 57 | 0.150 |
Why?
| | Administration, Inhalation | 3 | 2017 | 656 | 0.140 |
Why?
| | Lung | 5 | 2019 | 3664 | 0.140 |
Why?
| | Palliative Care | 2 | 2023 | 629 | 0.140 |
Why?
| | Severity of Illness Index | 4 | 2018 | 2674 | 0.140 |
Why?
| | Tonsillectomy | 1 | 2017 | 78 | 0.140 |
Why?
| | Comorbidity | 2 | 2022 | 1527 | 0.140 |
Why?
| | United States | 10 | 2023 | 12555 | 0.130 |
Why?
| | Education, Medical | 1 | 2018 | 239 | 0.130 |
Why?
| | Advisory Committees | 1 | 2016 | 212 | 0.130 |
Why?
| | Risk Factors | 3 | 2021 | 9000 | 0.130 |
Why?
| | Aged | 10 | 2023 | 19657 | 0.120 |
Why?
| | Patient Safety | 1 | 2017 | 281 | 0.120 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2017 | 231 | 0.120 |
Why?
| | Evidence-Based Medicine | 2 | 2016 | 693 | 0.120 |
Why?
| | Pulmonary Medicine | 1 | 2013 | 85 | 0.110 |
Why?
| | Health Policy | 1 | 2015 | 333 | 0.110 |
Why?
| | Myocardial Infarction | 1 | 2020 | 968 | 0.110 |
Why?
| | Intensive Care Units | 1 | 2017 | 635 | 0.110 |
Why?
| | Self Efficacy | 1 | 2016 | 366 | 0.110 |
Why?
| | History, 19th Century | 1 | 2012 | 61 | 0.110 |
Why?
| | Sleep Wake Disorders | 1 | 2016 | 241 | 0.110 |
Why?
| | Nursing | 1 | 2012 | 32 | 0.100 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2012 | 81 | 0.100 |
Why?
| | Socioeconomic Factors | 1 | 2016 | 1129 | 0.100 |
Why?
| | Affective Symptoms | 1 | 2011 | 50 | 0.100 |
Why?
| | Irritable Mood | 1 | 2011 | 51 | 0.100 |
Why?
| | History, 20th Century | 1 | 2012 | 281 | 0.100 |
Why?
| | Motor Skills | 1 | 2011 | 85 | 0.100 |
Why?
| | Education, Nursing | 1 | 2012 | 79 | 0.100 |
Why?
| | Italy | 2 | 2022 | 90 | 0.100 |
Why?
| | Evidence-Based Practice | 1 | 2012 | 193 | 0.090 |
Why?
| | Nurse Practitioners | 1 | 2011 | 107 | 0.090 |
Why?
| | Forced Expiratory Volume | 3 | 2008 | 520 | 0.090 |
Why?
| | Health Services Accessibility | 1 | 2016 | 781 | 0.090 |
Why?
| | Exercise Test | 3 | 2010 | 551 | 0.090 |
Why?
| | Tuberculosis | 1 | 2012 | 240 | 0.090 |
Why?
| | Exercise | 1 | 2020 | 1657 | 0.090 |
Why?
| | Gastroesophageal Reflux | 1 | 2011 | 248 | 0.080 |
Why?
| | Acute Lung Injury | 1 | 2012 | 310 | 0.080 |
Why?
| | Respiratory Function Tests | 4 | 2008 | 526 | 0.080 |
Why?
| | Europe | 3 | 2015 | 356 | 0.080 |
Why?
| | Middle Aged | 7 | 2018 | 27617 | 0.080 |
Why?
| | Treatment Outcome | 6 | 2018 | 9342 | 0.080 |
Why?
| | Cognition Disorders | 1 | 2011 | 529 | 0.070 |
Why?
| | Burnout, Professional | 1 | 2012 | 330 | 0.070 |
Why?
| | Physician-Patient Relations | 1 | 2010 | 490 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2018 | 6561 | 0.060 |
Why?
| | Video Recording | 1 | 2006 | 156 | 0.060 |
Why?
| | Metaphor | 1 | 2004 | 5 | 0.060 |
Why?
| | Psycholinguistics | 1 | 2004 | 17 | 0.060 |
Why?
| | Male | 11 | 2022 | 57801 | 0.060 |
Why?
| | Work of Breathing | 1 | 2003 | 1 | 0.060 |
Why?
| | Longitudinal Studies | 3 | 2003 | 2513 | 0.060 |
Why?
| | Monitoring, Physiologic | 1 | 2006 | 272 | 0.060 |
Why?
| | Self Disclosure | 1 | 2003 | 60 | 0.060 |
Why?
| | Adult | 3 | 2018 | 31512 | 0.060 |
Why?
| | Chronic Disease | 3 | 2015 | 1636 | 0.050 |
Why?
| | Frail Elderly | 1 | 2023 | 107 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2010 | 1185 | 0.050 |
Why?
| | Risk Assessment | 1 | 2010 | 3057 | 0.050 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2019 | 32 | 0.040 |
Why?
| | Theophylline | 1 | 2019 | 60 | 0.040 |
Why?
| | Cholinergic Antagonists | 1 | 2019 | 28 | 0.040 |
Why?
| | New Zealand | 1 | 2018 | 50 | 0.040 |
Why?
| | Time Factors | 2 | 2018 | 6412 | 0.040 |
Why?
| | Australia | 1 | 2018 | 212 | 0.040 |
Why?
| | Canada | 1 | 2018 | 340 | 0.040 |
Why?
| | Program Evaluation | 2 | 2013 | 845 | 0.040 |
Why?
| | Lung Transplantation | 1 | 2019 | 263 | 0.040 |
Why?
| | Patient Acceptance of Health Care | 1 | 2022 | 687 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2018 | 204 | 0.040 |
Why?
| | Breathing Exercises | 2 | 2006 | 22 | 0.040 |
Why?
| | Polysomnography | 1 | 2017 | 157 | 0.040 |
Why?
| | Evaluation Studies as Topic | 1 | 1996 | 182 | 0.030 |
Why?
| | Positive-Pressure Respiration | 1 | 1976 | 70 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 554 | 0.030 |
Why?
| | Delivery of Health Care | 1 | 2022 | 867 | 0.030 |
Why?
| | Patient Selection | 1 | 2019 | 676 | 0.030 |
Why?
| | Health Care Costs | 1 | 2018 | 394 | 0.030 |
Why?
| | Forced Expiratory Flow Rates | 1 | 1994 | 14 | 0.030 |
Why?
| | Total Lung Capacity | 1 | 1994 | 33 | 0.030 |
Why?
| | Ambulatory Care | 1 | 1998 | 482 | 0.030 |
Why?
| | Rehabilitation | 1 | 2013 | 15 | 0.030 |
Why?
| | Prognosis | 2 | 2008 | 3443 | 0.030 |
Why?
| | International Cooperation | 1 | 2013 | 177 | 0.030 |
Why?
| | North America | 1 | 2013 | 266 | 0.030 |
Why?
| | Models, Organizational | 1 | 2013 | 146 | 0.030 |
Why?
| | Reference Values | 1 | 1994 | 774 | 0.030 |
Why?
| | Benchmarking | 1 | 2013 | 172 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1785 | 0.030 |
Why?
| | Disease Management | 1 | 2016 | 571 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2016 | 523 | 0.030 |
Why?
| | Female | 6 | 2018 | 61565 | 0.030 |
Why?
| | Oxygen | 1 | 1976 | 854 | 0.030 |
Why?
| | Pediatric Nursing | 1 | 2011 | 40 | 0.030 |
Why?
| | Proton Pump Inhibitors | 1 | 2011 | 98 | 0.020 |
Why?
| | Asthma | 1 | 2003 | 2158 | 0.020 |
Why?
| | Referral and Consultation | 1 | 2013 | 648 | 0.020 |
Why?
| | Taiwan | 1 | 2008 | 19 | 0.020 |
Why?
| | Brazil | 1 | 2008 | 109 | 0.020 |
Why?
| | Reference Standards | 1 | 2008 | 176 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2008 | 82 | 0.020 |
Why?
| | China | 1 | 2008 | 175 | 0.020 |
Why?
| | Relaxation Therapy | 1 | 1987 | 14 | 0.020 |
Why?
| | Nursing Assessment | 1 | 1987 | 46 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2008 | 336 | 0.020 |
Why?
| | Social Support | 1 | 2010 | 542 | 0.020 |
Why?
| | Respiratory Muscles | 1 | 2006 | 36 | 0.020 |
Why?
| | Language | 1 | 2008 | 271 | 0.020 |
Why?
| | Posture | 1 | 1987 | 158 | 0.020 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 51 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2010 | 497 | 0.020 |
Why?
| | Survival Analysis | 1 | 2008 | 1267 | 0.020 |
Why?
| | Analgesics, Opioid | 1 | 2012 | 794 | 0.020 |
Why?
| | Program Development | 1 | 2006 | 357 | 0.010 |
Why?
| | Quality Assurance, Health Care | 1 | 2006 | 325 | 0.010 |
Why?
| | Energy Intake | 1 | 2006 | 447 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2008 | 1868 | 0.010 |
Why?
| | Statistics, Nonparametric | 1 | 2003 | 403 | 0.010 |
Why?
| | Respiratory Insufficiency | 1 | 2006 | 290 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2011 | 4596 | 0.010 |
Why?
| | Heart | 1 | 2006 | 631 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 2003 | 525 | 0.010 |
Why?
| | Body Composition | 1 | 2006 | 653 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3174 | 0.010 |
Why?
| | Data Collection | 1 | 2003 | 658 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2003 | 1293 | 0.010 |
Why?
| | Anxiety | 1 | 2006 | 845 | 0.010 |
Why?
| | Infant | 1 | 2011 | 8293 | 0.010 |
Why?
| | Depression | 1 | 2006 | 1132 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 4552 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2006 | 1515 | 0.010 |
Why?
| | Partial Pressure | 1 | 1976 | 29 | 0.010 |
Why?
| | Methods | 1 | 1976 | 67 | 0.010 |
Why?
| | Arteries | 1 | 1976 | 250 | 0.010 |
Why?
|
|
Lareau's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|